In a statement to WIRED, a Lilly spokesperson Niki Biro noted that, given its effectiveness, retatrutide is currently being targeted to those with high BMI or with obesity-related complications that require a high degree of weight loss, where the clinical need may be greater. Biro also cautions that retatrutide is an investigational molecule that is legally available only to participants in Lillys clinical trials
Perhaps thats why copper has been so easy to overlook
One tested sample turned out to be nothing more than sugar alcohol
Dillon EL, Sheffield-Moore M, Paddon-Jones D, Gilkison C, Sanford AP, Casperson SL, Jiang J, Chinkes DL, Urban RJ
The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinsons disease
Patients should consult their healthcare provider to determine the most appropriate approach based on their individual health needs and financial considerations